Dr. Pedram Ghasri, MD

Dr. Ghasri practices at Peyman Ghasri, MD, a Prof Corp. in Tarzana, California.

Dr. Ghasri's NPI, 1639429178, was assigned on September 12, 2012. Dr. Ghasri graduated from UC Irvine School of Medicine in 2011. Dr. Ghasri holds California license CA123798.

Dr. Ghasri's primary practice is Peyman Ghasri, MD, a Prof Corp., at 18555 W Ventura Blvd, Tarzana, CA 91356 in Los Angeles County. The practice phone is (818) 344-3376.

Dr. Ghasri's primary practice is Peyman Ghasri, MD, a Prof Corp. in Tarzana, California. The medical group on file is Castle Dermatology Institute. Dmand AI also links Dr. Ghasri to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghasri practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ghasri's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ghasri is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Ghasri's licenses on file in 2 states: California and Arizona.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and hives among the conditions Dr. Ghasri treats.

CMS data shows 9,407 Medicare services from Dr. Ghasri across 31 procedure codes in 2024, for 1,240 Medicare patients. Medicare paid $790,457 for them. Every service was in an office.

CMS counts 1,240 Medicare patients who saw Dr. Ghasri in 2024. The largest group is 65 to 74, with 609 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ghasri's median patient age at 63, with 52% women.

In 2024, Dr. Ghasri wrote 2,861 Medicare Part D claims for 815 patients. 95% of them were for generic drugs. CMS names the drug for 2,712 of them, across 34 drugs with 11 or more claims each, at $369,382 in total drug cost. In 2023, CMS named 2,816 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Ghasri for performance year 2024, reported as part of a group. Dr. Ghasri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,301 procedures of removal of skin lesions by Dr. Ghasri, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Ghasri, published from 2010 to 2017. 2010 was the busiest year, with 2. Dr. Ghasri has published most often in J Am Acad Dermatol. Dr. Ghasri's most frequent co-authors are Steven Richard Feldman, MD, Jennifer Kylien Chen, MD and Tushar S. Dabade, MD.

CMS Open Payments shows 1,182 general payments to Dr. Ghasri from 63 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Abbvie Inc. paid the most, $2,469.

Dr. Ghasri graduated from UC Irvine School of Medicine in 2011.

Dr. Ghasri is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.